Back to DE D. E. Shaw & Co., Inc.

EBSEBS
Showing 8 of 31 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in EMERGENT BIOSOLUTIONS INC

D. E. Shaw & Co., Inc. holds 900,108 shares of EBS (EMERGENT BIOSOLUTIONS INC), worth $7.5M as of 2026-Q2. The position was decreased (-10.3% shares). EBS represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$7.5M

Current Shares

900,108

Total Value Change

+$1.1M

Total Shares Change

+128,970

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
900,108
-10.3%
$7.5M0.0%$8.38
0
2026-Q1
Increased
1M
+38.8%
$8.3M0.0%$8.92
36
2025-Q4
Increased
723,217
+125.2%
$8.9M0.0%$12.16
44
2025-Q3
Decreased
321,167
-21.9%
$2.8M0.0%$8.94
0
2025-Q2
Increased
411,368
+51.1%
$2.6M0.0%$6.35
36
2025-Q1
Decreased
272,274
-28.9%
$1.3M0.0%$4.66
0
2024-Q4
Decreased
383,043
-50.3%
$3.7M0.0%$9.25
0
2024-Q3
Decreased
771,138
-6.8%
$6.4M0.0%$7.49
0

Other major holders of EBS: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used